Post-Marketing Study Of The Safety Of Tygacil (Tigecycline)

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

621 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-04-30

Study Completion Date

2010-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to collect post-marketing information on the safety of Tygacil in Filipino patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Open Label Non-comparative Clinical Trial of Tigecycline in Patients With Catheter Infection

NCT00419991

Staphylococcal Infections

COMPLETED PHASE4

Antibiotic Therapy for Infectious Diseases

NCT04937894

Infectious Disease

RECRUITING

Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia

NCT01602874

Community Acquired Bacterial Pneumonia Complicated Intra-Abdominal Infection

WITHDRAWN PHASE3

Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia

NCT00914888

Community Acquired Bacterial Pneumonia Complicated Intra-Abdominal Infection

WITHDRAWN PHASE3

The Population Pharmacokinetics Study of Tigecycline and Pharmacokinetics- Pharmacodynamics Index in Patients With Carbapenem Resistant Enterobacteriaceae Bloodstream Infection

NCT06049771

Carbapenem-resistant Enterobacteriaceae

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Three-thousand or 10% of total number of patients given tigecycline will be included in the study

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Complicated Skin and Skin Structure Infections Complicated Intra-abdominal Infections

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A

Tigecycline (Tygacil)

Intervention Type DRUG

This is a non-interventional study; patients are administered Tygacil as prescribed by their doctor as per registered indications stated in product label/insert (50 mg by Intravenous Injection).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Tigecycline (Tygacil)

This is a non-interventional study; patients are administered Tygacil as prescribed by their doctor as per registered indications stated in product label/insert (50 mg by Intravenous Injection).

Intervention Type DRUG